News

Filter

Current filters:

AbbVieAblynx

Ablynx and AbbVie sign deal over rheumatoid arthritis nanobody

Ablynx and AbbVie sign deal over rheumatoid arthritis nanobody

23-09-2013

Belgian drug developer Ablynx and US drugmaker AbbVie have entered into a global license agreement to…

AbbVieAblynxAnti-Arthritics/RheumaticsEuropeLicensingPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top